All News

As governments plough in $3 trillion to stimulate growth, 52 major companies and leading climate change experts argue for policies to promote low carbon technology.

Biotech organisations in the UK have expressed anger at a tripling of the license fees charged by the Human Tissue Authority, the UK's regulator.

The precarious position of the UK’s life sciences sector is underlined by fundraising failures among 295 of its members.